首页> 外文期刊>World Journal of Gastroenterology >Identification of tumor markers using two-dimensional electrophoresis in gastric carcinoma
【24h】

Identification of tumor markers using two-dimensional electrophoresis in gastric carcinoma

机译:二维电泳在胃癌中鉴定肿瘤标志物

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To study the differential expression of proteins in normal and cancerous gastric tissues, and further identify new molecular markers for diagnosis and prognosis of gastric carcinoma, as well as develop new therapeutic targets of the disease. METHODS: Matched pairs of tissues from 6 gastric cancer patients were analyzed for their two-dimensional electrophoresis (2DE) profiles. Soluble fraction proteins from human normal and cancerous gastric tissue were separated in the first dimension by isoelectric focusing on immobilized pH gradient (IPG, pH3-10) strips, and by 125 g/L sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) in the second dimension with silver nitrate staining. Protein differential expression was analyzed by use of image analysis software to find out candidates for gastric cancer-associated proteins. RESULTS: Nine protein spots overexpressed in tumor tissues as compared with noncancerous regions. In the next step, 9 tumor-specific spots were cut off from Coomassie Brilliant Blue staining gels, digested in gel with L-1-tosylamide-2-phenylethyl chloromethyl ketone (TPCK)-trypsin. Protein identification was done by peptide mass fingerprinting with matrix assisted laser desorption/ ionization-time of flight-mass spectrometry (MALDI-TOF-MS). In total, 5 tumor-specific protein spots corresponding to 5 different polypeptide chains were identified, including annexin V, carbonic anhydrase, prohibitin, fibrin beta and fibrinogen fragment D. Among these 5 spots, the potential significance of the differential expressions is discussed. CONCLUSION Differential expression analysis of proteomes may be useful for the development of new molecular markers for diagnosis and prognosis of gastric carcinoma.
机译:目的:研究蛋白质在胃癌组织和正常胃癌组织中的差异表达,为胃癌的诊断和预后鉴定提供新的分子标志物,并为胃癌的治疗提供新的靶点。方法:对6例胃癌患者的配对组织进行二维电泳(2DE)分析。通过等电聚焦在固定的pH梯度(IPG,pH3-10)试纸上,并通过125 g / L十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE),一维分离人类正常和胃癌组织中的可溶性级分蛋白。第二维用硝酸银染色。通过使用图像分析软件分析蛋白质差异表达,以寻找与胃癌相关的蛋白质的候选物。结果:与非癌性区域相比,在肿瘤组织中过表达了九个蛋白质斑点。在下一步中,从考马斯亮蓝染色凝胶上切下9个肿瘤特异性斑点,并在凝胶中用L-1-甲苯磺酰胺-2-苯基乙基氯甲基酮(TPCK)-胰蛋白酶消化。蛋白质鉴定是通过肽质量指纹图谱和基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)进行的。总共鉴定出对应于5条不同多肽链的5个肿瘤特异性蛋白斑点,包括膜联蛋白V,碳酸酐酶,禁止素,血纤蛋白β和血纤蛋白原片段D。在这5个斑点中,讨论了差异表达的潜在意义。结论蛋白质组差异表达分析可能有助于开发新的诊断和预后分子标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号